Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome - de Miguel, A; Cuellas, C; Diego, A; Samaniego, B (Rev Esp Cardiol, 2009)
et al.